Description
GLP- 2
Form: Lyophilized Powder | Molecular Weight: 4813.5 g/mol | CAS: 2023788-19-2
Research Applications
Tirzepatide is a dual GIP and GLP-1 receptor agonist, making it a highly researched compound in metabolic science. Preclinical studies examine its simultaneous activation of both GIP and GLP-1 receptor pathways, its effects on insulin and glucagon secretion in cell models, and its role in energy homeostasis research. It is a reference standard of significant current interest in obesity and metabolic disorder research models.
This product is intended strictly for in vitro laboratory and research use only. Not for human or veterinary consumption.
For laboratory research only. No human or veterinary use.






Reviews
There are no reviews yet.